Table 2 hAR inhibitory activities of the Kampo formulations
From: Inhibitory activities of selected Kampo formulations on human aldose reductase
Kampo formulation | IC50 a) | |
|---|---|---|
μg/mL | μUnit/mL | |
Chotosan | 43.6 (±3.1) | 5.81 |
Yokukansan | 48.9 (±6.8) | 6.52 |
Keishikajutsubuto | 50.2 (±3.5) | 6.69 |
Goshajinkigan | 56.7 (±22.3) | 7.56 |
Sokeikakketuto | 68.4 (±9.2) | 9.12 |
Shichimotsukokato | 69.2 (±11.1) | 9.23 |
Hachimijiogan | 71.6 (±44.0) | 9.55 |
Yokukansankachinpihange | 83.4 (±10.4) | 11.12 |
epalrestat b) | 0.014 (±0.003) | 0.098 |